Where Global Innovation
and Capital Meet
Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Page 8

Promethera Biosciences fires its way to series D

UCL spinout Promethera Biosciences has increased its series D round to $44.4m with a $33.1m Mitsui and Medipal-backed extension, adding to Itochu’s initial investment earlier this year.

May 8, 2019

Investors load up Astroscale series D to $80m

The space debris removal company has raised another $30m for its series D round from investors including UTokyo Innovation Platform and has now received $132m in total.

Apr 15, 2019

Ahren adds gravity to Graphcore’s $200m series D

Ahren Innovation Capital has been confirmed as an investor in a round that brought University of Bristol-linked machine intelligence technology developer Graphcore’s total to $310m.

Mar 21, 2019

Big deal: Oxford PV begins capturing series D

Goldwind, Legal & General and Equinor have all taken part in a series D that achieved a $41m first close and boosted the Oxford spinout’s total equity and debt to more than $118m.

Mar 18, 2019

ClearMotion rides investor interest to raise $115m

Microsoft, Bridgestone and Qualcomm all contributed to a series D round for MIT spinout ClearMotion, which emerged from stealth earlier last year with $130m in funding.

Jan 11, 2019

Itochu kicks off Promethera's series D round

UCL spinout Promethera Biosciences has received $11.3m in series D funding from Itochu and $16.6m in a convertible debt round backed by Sosei.

Jan 4, 2019

Graphcore absorbs $200m in series D funding

Bristol-linked Graphcore has raised cash from Microsoft, Samsung, BMW i Ventures, Robert Bosch Venture Capital and Dell Technologies Capital at a valuation of $1.7bn.

Dec 19, 2018

AutoGrid charges $32m series D

AutoGrid, the distributed energy management platform backed by Stanford, will use the capital from the Eon, CLP, Innogy, Total, Ørsted and Tenaska-backed round to boost hiring.

Sep 13, 2018

PhaseBio attracts $34m in series D round

Existing backers AstraZeneca and Johnson & Johnson returned for a round that will advance PhaseBio's orphan disease drug pipeline, based on research from Duke University.

Sep 7, 2018

Outset originates $132m series D

Baxter Ventures has participated in a series D round for Outset Medical, a spinout of Oregon State University.

Aug 29, 2018

© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here